We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

221 hedge funds and large institutions have $2.09B invested in Ironwood Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 67 increasing their positions, 78 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 29

4% more funds holding

Funds holding: 212 → 221 (+9)

5% more capital invested

Capital invested by funds: $2B → $2.09B (+$92.9M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.39% less ownership

Funds ownership: 105.03% → 104.64% (-0.39%)

14% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 78

68% less call options, than puts

Call options by funds: $238K | Put options by funds: $734K

Holders
221
Holders Change
+9
Holders Change %
+4.25%
% of All Funds
3.49%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
39
Increased
67
Reduced
78
Closed
29
Calls
$238K
Puts
$734K
Net Calls
-$496K
Net Calls Change
-$7.51M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$14.1M
2
Two Sigma Investments
Two Sigma Investments
New York
+$10.2M
3
PI
Putnam Investments
Massachusetts
+$8.25M
4
RA
Royce & Associates
New York
+$7.8M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$7.14M

Top Sellers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
-$35M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$24.3M
3
BCM
Brown Capital Management
Maryland
-$23.3M
4
Goldman Sachs
Goldman Sachs
New York
-$7.95M
5
FP
Foundry Partners
Minnesota
-$6.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$13.2M -$6.16M -537,702 -34%
PAMS
27
Pictet Asset Management (Switzerland)
Switzerland
$12.4M -$150K -13,122 -1%
Allspring Global Investments
28
Allspring Global Investments
North Carolina
$11.9M +$21.7K +1,890 +0.2%
BM
29
Bridger Management
New York
$11.7M – – –
Two Sigma Investments
30
Two Sigma Investments
New York
$11.2M +$10.2M +888,888 New
Citadel Advisors
31
Citadel Advisors
Florida
$10.5M +$5.55M +484,521 +138%
JP Morgan Chase
32
JP Morgan Chase
New York
$9.97M -$5.55M -484,108 -38%
GLA
33
Great Lakes Advisors
Illinois
$9.41M -$2.14M -186,368 -20%
ECM
34
ExodusPoint Capital Management
New York
$9.23M -$4.78M -416,978 -36%
Two Sigma Advisers
35
Two Sigma Advisers
New York
$9.04M +$7.14M +622,500 +650%
HP
36
HealthInvest Partners
Sweden
$8.93M -$229K -20,000 -3%
Invesco
37
Invesco
Georgia
$8.56M -$937K -81,716 -11%
Deutsche Bank
38
Deutsche Bank
Germany
$8.46M +$3.02M +263,859 +65%
American Century Companies
39
American Century Companies
Missouri
$8.29M +$925K +80,672 +14%
Bank of America
40
Bank of America
North Carolina
$7.54M -$230K -20,046 -3%
Comerica Bank
41
Comerica Bank
Texas
$7.3M +$49.2K +4,290 +0.7%
1M
42
13D Management
New York
$7.08M -$570K -49,750 -8%
Wells Fargo
43
Wells Fargo
California
$6.9M -$498K -43,419 -7%
PPA
44
Parametric Portfolio Associates
Washington
$6.72M -$119K -10,385 -2%
MFP
45
Michael F. Price
$6.55M – – –
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$5.95M +$225K +19,652 +4%
First Trust Advisors
47
First Trust Advisors
Illinois
$5.77M +$2.08M +181,729 +66%
Rafferty Asset Management
48
Rafferty Asset Management
New York
$5.76M -$213K -18,594 -4%
Barclays
49
Barclays
United Kingdom
$5.74M +$2.68M +233,894 +105%
AQR Capital Management
50
AQR Capital Management
Connecticut
$5.69M +$264K +23,060 +5%
1
2
3 4 5

IRWD Hedge Fund Activity: Q1 2022 in Review

221 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q1 2022, worth a combined $2.09B — up 4.6% from $2B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new IRWD positions and 29 closed out — a net gain of 10 holders — while 67 added to existing stakes and 78 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $14.1M. The largest seller was Camber Capital Management, exiting entirely with an estimated $35M sold.

  • 221 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q1 2022, up from 212 in Q4 2021.
  • Funds reported $2.09B of Ironwood Pharmaceuticals stock for Q1 2022, up 4.6% quarter-over-quarter.
  • 39 funds opened new Ironwood Pharmaceuticals positions in Q1 2022 and 29 closed out, a net change of +10 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q1 2022 was Morgan Stanley, an estimated $14.1M added.
  • The largest Ironwood Pharmaceuticals seller in Q1 2022 was Camber Capital Management, an estimated $35M sold.

Based on aggregated 13F filings for Q1 2022.